Valuation: ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 15.83B 2.34B 2.04B 1.9B 1.74B 3.29B 224B 3.34B 22.36B 8.77B 111B 8.8B 8.61B 374B P/E 2026 *
30.4x
P/E 2027 * -153x
Enterprise Value 15.83B 2.34B 2.04B 1.9B 1.74B 3.29B 224B 3.34B 22.36B 8.77B 111B 8.8B 8.61B 374B EV / Sales 2026 *
14.7x
EV / Sales 2027 * 12.6x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day+4.13%
1 week+4.28%
1 month-11.04%
3 months-14.84%
6 months+7.13%
Current year+5.22%
1 week 33.7
Extreme 33.7
35.66
1 month 33.41
Extreme 33.41
44.8
Current year 29.31
Extreme 29.31
45.88
1 year 29.31
Extreme 29.31
76.88
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.5778
81.48
Manager TitleAgeSince
Chief Executive Officer 52 2015-11-10
Director of Finance/CFO 60 2015-11-10
Investor Relations Contact 38 2020-12-30
Director TitleAgeSince
Chairman 52 2015-11-10
Director/Board Member 58 2015-11-10
Chairman 50 2015-11-10
Date Insider Type Main position Quantity % Market Cap.
1/5/26 Buy

Director

4,200 0.0010%
11/24/25 Buy

Director

7,000 0.0017%
9/1/23 Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
+4.13%+4.28%-53.38%+46.05% 2.34B
-0.53%+2.54%+22.14%+75.34% 50.03B
+2.39%+0.09%+53.92%+115.49% 36.6B
+0.46%+4.44%-1.97%+26.10% 12.47B
+1.05%+1.63%+18.73%+79.26% 11.77B
-1.33%-0.76%+30.73%+130.67% 9.04B
-2.83%-5.16%+40.00%-12.76% 7.03B
+0.51%+1.46%+13.46%+32.66% 6.79B
+1.99%+1.91%+8.03%+186.16% 6.6B
+0.39%+3.39%-35.25%+8.97% 5.49B
Average +0.58%+0.94%+9.64%+68.79% 14.82B
Weighted average by Cap. +0.44%+1.26%+24.71%+80.68%

Financials

2026 *2027 *
Net sales 1.08B 160M 139M 129M 119M 224M 15.26B 228M 1.52B 598M 7.6B 600M 587M 25.48B 1.26B 186M 162M 151M 138M 261M 17.78B 265M 1.78B 697M 8.85B 699M 684M 29.68B
Net income 526M 77.87M 67.69M 63.01M 57.85M 109M 7.43B 111M 743M 291M 3.7B 292M 286M 12.41B -102M -15.1M -13.13M -12.22M -11.22M -21.18M -1.44B -21.51M -144M -56.52M -718M -56.71M -55.47M -2.41B
Net Debt - -
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
26-07-31 CN¥35.30 +4.13% 9,653,548
26-07-30 CN¥33.90 -3.12% 7,783,121
26-07-29 CN¥34.99 +1.54% 9,081,549
26-07-28 CN¥34.46 -1.71% 7,260,041
26-07-27 CN¥35.06 +3.57% 9,887,720

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300723 Stock